Tag: Glenmark Pharma

Stocks that will see action today: November 14, 2024

Tata Power Company’s subsidiary Tata Power Renewable Energy, has commissioned floating solar projects of 126 MW in Omkareshwar, Madhya Pradesh.

Representative Image: The company initiated the Class III recall on September 30. (Photo: Shutterstock) 2 min read Last Updated :

Glenmark Life Sciences (GLS) shares dipped over 4 per cent, ending the day at ₹842.85, on the BSE, following the

Glenmark Specialty SA of Glenmark Pharmaceutical has received final approval from the United States Food & Drug Administration (USFDA) for

Glenmark initiated Class II recall of the drug across the US on March 26 this year | File image 2

Shares of Glenmark Pharmaceuticals slipped 3 per cent to Rs 802.25 on the BSE during Friday’s trade after the

Lupine has been in the news lately. After last week’s massive approval of gSpiriva HandiHaler, there have been media reports

Glenmark Pharmaceuticals on Friday reported a consolidated net loss of Rs. 403 crore for the March 2023 quarter due to